{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=6-minute+withdrawal+time&page=2", "query": { "intervention": "6-minute withdrawal time", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 40, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=6-minute+withdrawal+time&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=6-minute+withdrawal+time&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-03T22:57:12.586Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04634539", "title": "Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Pancreatic Adenocarcinoma", "Pancreatic Cancer", "Pancreatic Ductal Adenocarcinoma" ], "interventions": [ { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Nab-paclitaxel", "type": "DRUG" }, { "name": "L-glutamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jun Gong, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2021-05-13", "completion_date": "2025-06-17", "has_results": false, "last_update_posted_date": "2025-08-06", "last_synced_at": "2026-10-03T22:57:12.586Z", "location_count": 2, "location_summary": "Beverly Hills, California • Los Angeles, California", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04634539" }, { "nct_id": "NCT00974402", "title": "Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Post-Traumatic Stress Disorders", "Stress Disorders", "Combat Disorders" ], "interventions": [ { "name": "Cognitive Behavioral Therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "The University of Texas Health Science Center at San Antonio", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2008-03", "completion_date": "2012-06", "has_results": false, "last_update_posted_date": "2014-09-18", "last_synced_at": "2026-10-03T22:57:12.586Z", "location_count": 3, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00974402" }, { "nct_id": "NCT06104280", "title": "Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Opioid Use Disorder", "Sleep Disturbance" ], "interventions": [ { "name": "Post-Illumination Pupillary Response (PIPR)", "type": "OTHER" }, { "name": "Polysomnography", "type": "OTHER" }, { "name": "Multiple Sleep Latency Test", "type": "OTHER" }, { "name": "Ecological Momentary Assessments", "type": "BEHAVIORAL" }, { "name": "Actigraphy", "type": "DEVICE" }, { "name": "DLMO", "type": "OTHER" }, { "name": "Melatonin Suppression Test", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BEHAVIORAL", "DEVICE" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 200, "start_date": "2025-01-06", "completion_date": "2029-01-01", "has_results": false, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-10-03T22:57:12.586Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT06104280" }, { "nct_id": "NCT05014815", "title": "Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC)", "Nonsmall Cell Lung Cancer, Stage IIIB", "Nonsmall Cell Lung Cancer, Stage IV" ], "interventions": [ { "name": "Ociperlimab", "type": "DRUG" }, { "name": "Tislelizumab", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Nab paclitaxel", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BeiGene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 272, "start_date": "2021-11-16", "completion_date": "2024-09-04", "has_results": true, "last_update_posted_date": "2025-09-16", "last_synced_at": "2026-10-03T22:57:12.586Z", "location_count": 11, "location_summary": "Los Angeles, California • Iowa City, Iowa • Las Vegas, Nevada + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "New Hyde Park", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05014815" }, { "nct_id": "NCT05575219", "title": "Protocolized Initiation of Clonidine to Prevent Dexmedetomidine Withdrawal", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Withdrawal; Therapeutic Substance" ], "interventions": [ { "name": "Clonidine (without protocolized initiation)", "type": "DRUG" }, { "name": "Clonidine (protocolized initiation)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Weeks", "maximum_age": "18 Years", "sex": "ALL", "summary": "4 Weeks to 18 Years" }, "enrollment_count": 128, "start_date": "2022-10-08", "completion_date": "2024-02-15", "has_results": true, "last_update_posted_date": "2025-01-28", "last_synced_at": "2026-10-03T22:57:12.586Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05575219" }, { "nct_id": "NCT02083679", "title": "Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Carcinoma, Non-Small-Cell Lung" ], "interventions": [ { "name": "Part 1: Sym004 6 mg/kg + Cisplatin/Gemcitabine", "type": "DRUG" }, { "name": "Part 1: Sym004 6 mg/kg + Cisplatin/Pemetrexed", "type": "DRUG" }, { "name": "Part 1: Sym004 6 mg/kg + Carboplatin/Paclitaxel", "type": "DRUG" }, { "name": "Part 1: Sym004 6/12 mg/kg + Carboplatin/Paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "EMD Serono", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2014-07", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2016-10-25", "last_synced_at": "2026-10-03T22:57:12.586Z", "location_count": 1, "location_summary": "Rockland, Massachusetts", "locations": [ { "city": "Rockland", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02083679" }, { "nct_id": "NCT01116986", "title": "Identifying Optimal Smoking Cessation Intervention Components (Cessation)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Smoking", "Smoking Cessation", "Nicotine Dependence" ], "interventions": [ { "name": "Counseling before quit attempt", "type": "BEHAVIORAL" }, { "name": "Minimal In-person counseling during quit attempt", "type": "BEHAVIORAL" }, { "name": "Intensive in-person counseling during the quit attempt", "type": "BEHAVIORAL" }, { "name": "Minimal phone counseling during the quit attempt", "type": "BEHAVIORAL" }, { "name": "Intensive phone counseling during the quit attempt", "type": "BEHAVIORAL" }, { "name": "Long Term Nicotine Patch+ Nicotine Gum During Quit Attempt", "type": "DRUG" }, { "name": "Short Term Nicotine Patch + Nicotine Gum during the quit attempt", "type": "DRUG" }, { "name": "Pre-Quit Nicotine Gum", "type": "DRUG" }, { "name": "Pre-Quit Nicotine Patch", "type": "DRUG" }, { "name": "Pre-Quit Nicotine Patch + Pre-Quit Nicotine Gum", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 637, "start_date": "2010-06", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2015-12-11", "last_synced_at": "2026-10-03T22:57:12.586Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01116986" }, { "nct_id": "NCT04515472", "title": "Effect of Gender Affirming Hormone Therapy on Glucose Metabolism", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Transgender Persons" ], "interventions": [ { "name": "Botnia Clamp", "type": "DRUG" }, { "name": "Withdrawal of Gender Affirming Hormone Therapy (GAHT)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "The University of Texas Health Science Center at San Antonio", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2020-06-17", "completion_date": "2025-03-17", "has_results": false, "last_update_posted_date": "2025-07-20", "last_synced_at": "2026-10-03T22:57:12.586Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04515472" }, { "nct_id": "NCT00735696", "title": "A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non Small Cell Lung Cancer" ], "interventions": [ { "name": "Ramucirumab", "type": "BIOLOGICAL" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 41, "start_date": "2009-01", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2014-12-29", "last_synced_at": "2026-10-03T22:57:12.586Z", "location_count": 7, "location_summary": "Beverly Hills, California • San Francisco, California • Aurora, Colorado + 4 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "New York", "state": "New York" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00735696" }, { "nct_id": "NCT01802008", "title": "Comparison of Adenoma Detection Miss Rates at Colonoscopy Associated With Different Withdrawal Times", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Adenoma and/or Adenocarcinoma", "Adenoma" ], "interventions": [ { "name": "3-minute withdrawal time", "type": "PROCEDURE" }, { "name": "6-minute withdrawal time", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2012-09", "completion_date": "2013-08", "has_results": false, "last_update_posted_date": "2015-04-30", "last_synced_at": "2026-10-03T22:57:12.586Z", "location_count": 2, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01802008" } ] }